CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug trial offers hope for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new oral medication called BBI-355, both alone and in combination with other drugs, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the treatment can shrink…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Last-Chance cancer drug access program opens for desperate patients
Disease control APPROVED_FOR_MARKETINGThis program provides compassionate access to the immunotherapy drug cemiplimab for patients with advanced non-small cell lung cancer, basal cell carcinoma, or cutaneous squamous cell carcinoma. It's designed for individuals who have exhausted all other approved treatment options…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC